Evidence map›Paper›PMID 37078793›Full record

ArticleCancer research2023

Ubiquitin Ligases Siah1a/2 Control Alveolar Macrophage Functions to Limit Carcinogen-Induced Lung Adenocarcinoma.

Marzia Scortegagna, Yuanning Du, Linda M Bradley, Kun Wang, Alfredo Molinolo, Eytan Ruppin, Rabi Murad, Ze'ev A Ronai

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Noncanonical PI(4,5)PScience advances · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marzia ScortegagnaNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.ORCID 0009-0006-0788-3194
Yuanning DuNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.ORCID 0000-0001-7078-1808
Linda M BradleyNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.ORCID 0000-0002-8697-8565
Kun WangCancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0001-8923-8557
Alfredo MolinoloDepartment of Pathology, University of California, San Diego, California.ORCID 0000-0001-8412-2889
Eytan RuppinCancer Data Science Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-7862-3940
Rabi MuradNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.ORCID 0009-0004-5297-8307
Ze'ev A RonaiNCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California.ORCID 0000-0002-3859-0400
Discovery Institute · USNational Institutes of Health · USUniversity of California System · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI ELENA B PASQUALE · 1985 to 2026
$107.2M
SCIENTIFIC INFORMATION FACILITYP30CA017613 · NCI · INSTITUTE FOR CANCER PREVENTION · PI NIXON, DANIEL W · 1985 to 2005
$13.1M
Rewired Signaling at the Nexus of Melanoma Metastasis and ResistanceR35CA197465 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RONAI, ZEEV A. · 2016 to 2022
$7.9M
NCI NIH HHS P30 CA017613NCI NIH HHS P30 CA030199NCI NIH HHS R35 CA197465
6 · The paper itself

Abstract

Cellular components of the tumor microenvironment, including myeloid cells, play important roles in the progression of lung adenocarcinoma (LUAD) and its response to therapy. Here, we characterize the function of the ubiquitin ligases Siah1a/2 in regulating the differentiation and activity of alveolar macrophages (AM) and assess the implication of Siah1a/2 control of AMs for carcinogen-induced LUAD. Macrophage-specific genetic ablation of Siah1a/2 promoted accumulation of AMs with an immature phenotype and increased expression of protumorigenic and pro-inflammatory Stat3 and β-catenin gene signatures. Administration of urethane to wild-type mice promoted enrichment of immature-like AMs and lung tumor development, which was enhanced by macrophage-specific Siah1a/2 ablation. The profibrotic gene signature seen in Siah1a/2-ablated immature-like macrophages was associated with increased tumor infiltration of CD14+ myeloid cells and poorer survival of patients with LUAD. Single-cell RNA-seq confirmed the presence of a cluster of immature-like AMs expressing a profibrotic signature in lungs of patients with LUAD, a signature enhanced in smokers. These findings identify Siah1a/2 in AMs as gatekeepers of lung cancer development. SIGNIFICANCE: The ubiquitin ligases Siah1a/2 control proinflammatory signaling, differentiation, and profibrotic phenotypes of alveolar macrophages to suppress lung carcinogenesis.

Indexed as

Adenocarcinoma of LungLung NeoplasmsMacrophages, AlveolarUbiquitin-Protein LigasesAnimalsMaleMiceMice, Inbred C57BLMice, KnockoutTumor MicroenvironmentSiah1a protein, mouseSiah2 protein, mouseUbiquitin-Protein Ligases

Identifiers

PMID37078793
PMCPMC10330299
OpenAlexW4366463560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.